Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia

Bone Marrow Transplantation

Volumn 20, Issue 3, 1997, Pages 235-241

  Gardiner, N ^a   Lawler, M ^a   O'Riordan, J ^a   DeArce, M ^b   Humphries, P ^b   McCann, S R ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

BMT; Chimaerism; CML; MRD

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CELL SURVIVAL; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONDITIONING; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; LEUKEMIA CELL; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TANDEM REPEAT;

EID: 0030806786     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700861     Document Type: Article

References (31)

1. Thomas ED, Clift A, Feter A et al. Marrow transplantation for the treatment of chronic myeloid leukaemia. Ann Intern Med 1986; 104: 155-161.
2. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myeloid leukaemia in chronic phase: increased rates of relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
3. Arcese W, Goldman JM, D'Arcangelo E et al. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Blood 1993; 82: 3211-3219.
4. McCann SR, Lawler M. Mixed chimaerism: detection and significance following BMT. Bone Marrow Transplant 1993; 11: 91-94.
5. Socie G, Lawler M, Gluckman E et al. Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular era. Leukemia Res 1995; 19: 497-504.
6. Petz LD, Yam P, Wallace RB et al. Mixed hematopoietic chimerism following bone marrow transplantation for hematological malignancies. Blood 1987; 70: 1331-1337.
7. Bertheas MF, Maraninchi D, Lafage M et al. Partial chimerism after T-cell depleted allogeneic bone marrow transplantation in leukemic HLA matched patients: a cytogenetic documentation. Blood 1988; 72: 89-93.
8. Roy DC, Tantravahi R, Murray C et al. Natural history of mixed chimerism after bone marrow transplantation with CD6 depleted allogeneic marrow: a stable equilibrium. Blood 1990; 75: 296-304.
9. Offit K, Burns JP, Cunningham I et al. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukaemia patients after T cell depleted bone marrow transplantation. Blood 1990; 75: 1346-1355.
10. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 1991; 77: 2504-2514.
11. Roux E, Helg C, Chapuis B et al. Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction. Blood 1992; 79: 2775-2783.
12. McKinnon S, Barnett L, Bourhis JH et al. Myeloid and lymphoid chimerism after T cell depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood 1992; 80: 3235-3241.
13. Roux E, Abdi K, Speiser D et al. Characterization of mixed chimerism in patients with chronic myeloid leukaemia transplanted with T cell depleted bone marrow: involvement of different hematologic lineages before and after relapse. Blood 1993; 81: 243-248.
14. McKinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 3409-3416.
15. Morgan GJ, Hughes T, Janssen JWG et al. Polymerase chain reaction for detection of residual disease. Lancet 1989; i: 928-929.
16. Roth MS, Antin JH, Bingham EL, Ginsburg D. Detection of Philadelphia chromosome positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989; 74: 882-885.
17. Gabert J, Thuret I, Lafage M et al. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. Lancet 1989; ii: 1125-1128.
18. Hughes TP, Morgan GJ, Martial P, Goldman JM. Detection of residual leukemia after bone marrow transplantation for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874-878.
19. Roth MS, Antin JH, Ash R et al. Prognostic significance of Philadelphia chromosome positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Blood 1992; 79: 276-282.
20. Cross NCP, Hughes TP, Feng L et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft versus host disease and relapse. Br J Haematol 1993; 84: 67-74.
21. Miyamura K, Barrett AJ, Kodera Y, Saito H. Minimal residual disease after bone marrow transplantation for chronic myeloid leukemia and implications for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplant 1994; 14: 201-209.
22. Radich JP, Gehly G, Gooley T et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia. Blood 1995; 85: 2632-2638.
23. McKinnon S, Barnett L, Heller G. Polymerase chain reaction is highly predictive of relapse in patients following T cell depleted allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1996; 17: 643-647.
24. Gaiger A, Henn T, Horth E et al. Increase of BCR-ABL chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood 1995; 86: 2371-2378.
25. Cross NCP, Feng L, Chase A et al. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukaemia patients after bone marrow transplantation. Blood 1993; 82: 1929-1936.
26. Molloy K, Goulden N, Lawler M et al. Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. Blood 1996; 87: 3027-3031.
27. Chomczynski P, Sacchi N. Single step isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
28. Longo N, Berninger NS, Hartley JL. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990; 93: 125-128.
29. Roux E, Helg C, Chapuis B et al. Mixed chimerism after bone marrow transplantation and the risk of relapse. Blood 1994; 83: 4385-4386.
30. Elmaagacli AH, Becks HW, Beelen DW et al. Detection of minimal residual disease and persistence of host type hematopoiesis: a study in 28 patients after sex mismatched, non T cell-depleted allogeneic bone marrow transplantation for Philadelphia positive chronic myeloid leukemia. Bone Marrow Transplant 1995; 16: 823-829.
31. Lin F, Kirkland MA, Van Rhee F et al. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 1996; 18: 1147-1152.